Menu
Search
|

Menu

Close
X

Dynasil Corporation of America DYSL.OQ (NASDAQ Stock Exchange Capital Market)

1.38 USD
+0.04 (+2.99%)
As of 1:30 AM IST
chart
Previous Close 1.34
Open 1.37
Volume 304
3m Avg Volume 4,127
Today’s High 1.38
Today’s Low 1.36
52 Week High 2.04
52 Week Low 1.13
Shares Outstanding (mil) 17.06
Market Capitalization (mil) 24.40
Forward P/E 8.12
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY18
19
FY17
37
FY16
43
FY15
41
EPS (USD)
FY18
0.029
FY17
0.131
FY16
0.041
FY15
-0.015
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
8.12
32.76
Price to Sales (TTM)
vs sector
0.63
5.73
Price to Book (MRQ)
vs sector
1.28
5.47
Price to Cash Flow (TTM)
vs sector
6.46
23.29
Total Debt to Equity (MRQ)
vs sector
17.67
16.84
LT Debt to Equity (MRQ)
vs sector
6.72
12.51
Return on Investment (TTM)
vs sector
13.80
14.61
Return on Equity (TTM)
vs sector
17.53
16.34

EXECUTIVE LEADERSHIP

Robert Bowdring
Chief Financial Officer, Controller, Since 2016
Salary: --
Bonus: --
William Hagan
Lead Independent Director, Since 2013
Salary: --
Bonus: --
Peter Sulick
Chairman of the Board, President, Chief Executive Officer, Since 2014
Salary: $300,000.00
Bonus: $29,250.00
Craig Dunham
Independent Director, Since 2015
Salary: $110,000.00
Bonus: $86,711.00
Lawrence Fox
Independent Director, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

313 Washington St Ste 403
NEWTON   MA   02458-1626

Phone: +1617.6686855

Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company operates through three segments, including Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation, Hilger Crystals, Ltd. and Evaporated Metal Films Corporation, which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation, a medical technology incubator, which owns rights to certain early-stage medical technologies.

SPONSORED STORIES